References
- Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031
- Manwani D, Frenette PS. Vaso-occlusion in sickle cell disease: Pathophysiology and novel targeted therapies. Blood. 2013;122(24):3892–3898
- Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: A critical reappraisal. Blood. 2012;120(18):3647–3656
- Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148(2):94–101
- Davis H, Moore RM Jr, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep. 1997;112(1):40–43
- Lanzkron S, Carroll CP, Haywood C Jr. The burden of emergency department use for sickle-cell disease: An analysis of the national emergency department sample database. Am J Hematol. 2010;85(10):797–799
- Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: National and state estimates. Am J Hematol. 2010;85(1):77–78
- Ballas SK, Lusardi M. Hospital readmissions for adult acute sickle cell painful episodes: Frequency, etiology, and prognostic significance. Am J Hematol. 2005;79(1):17–25
- Carroll CP, Haywood C Jr, Fagan P, Lanzkron S. The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization. Am J Hematol. 2009;84(10):666–670
- Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303(13):1288–1294
- Hunt SE, Sharma N. Transition from pediatric to adult care for patients with sickle cell disease. JAMA. 2010;304(4):408–409
- Shankar SM, Arbogast PG, Mitchel E, et al. Medical care utilization and mortality in sickle cell disease: A population-based study. Am J Hematol. 2005;80(4):262–270
- Carroll CP, Haywood C Jr, Lanzkron S. Prediction of onset and course of high hospital utilization in sickle cell disease. J Hosp Med. 2011;6(5):248–255
- Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11–16
- Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–1428
- Frei-Jones MJ, Field JJ, DeBaun MR. Risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell disease. Pediatr Blood Cancer. 2009;52(4):481–485
- Lanzkron S, Strouse JJ, Wilson R, et al. Systemic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med. 2008;148(12):939–955
- Ballas SK, Bauserman RL, McCarthy WF, et al. Hydroxyurea and acute painful crises in sickle cell anemia: Effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contracts, and at home. J Pain Symptom Manage. 2010;40(6):870–882
- Glaser B, Strauss AL. The constant comparative method of qualitative analysis. In: Glaser B, Strauss AL, Eds. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago, IL: Aldine. 1967:137–185
- Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048
- Miller ST, Kim HY, Weiner D, et al. Inpatient management of sickle cell pain: A “snapshot” of current practice. Am J Hematol. 2012;87(3):333–336
- van Beers EJ, van Tuijn CF, Nieuwkerk PT, et al. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a random controlled trial. Am J Hematol. 2007;82(11):955–960
- Ezenwa MO, Molokie RE, Wang ZJ, et al. Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease. J Pain Symptom Manage. 2014;48(1):65–74
- Haywood C, Lanzkron S, Ratanawongsa N, et al. Hospital self-discharge among adults with sickle-cell disease (SCD): Associations with trust and interpersonal experiences with care. J Hosp Med. 2010;5(5):289–294
- Weisberg D, Balf-Soran G, Becker W, et al. “I’m talking about pain”: Sickle cell disease patients with extremely high hospital use. J Hosp Med. 2013;8(1):42–46
- Dampier C, LeBeau P, Rhee S, et al. Health-related quality of life in adults with sickle cell disease (SCD): A report from the comprehensive sickle centers clinical trial consortium. Am J Hematol. 2011;86(2):203–205
- Raphael JL, Oyeku SO. Sickle cell disease pain management and the medical home. Hematology Am Soc Hematol Educ Program. 2013;2013:433–438. doi: 10.1182/asheducation-2013.1.433
- Wilkie DJ, Johnson B, Mack AK, et al. Sickle cell disease: An opportunity for palliative care across the life span. Nurs Clin North Am. 2010;45(3):375–397
- Benjamin L. Pain management in sickle cell disease: Palliative care begins at birth? Hematology Am Soc Hematol Educ Program. 2008;2008:466–474. doi: 10.1182/asheducation-2008.1.466